Published ahead of print on June 9, 2005, doi:10.1165/rcmb.2004-0372OC
American Journal of Respiratory Cell and Molecular Biology. Vol. 33, pp. 303-314, 2005
© 2005 American Thoracic Society DOI: 10.1165/rcmb.2004-0372OC
Gob-5 Is Not Essential for Mucus Overproduction in Preclinical Murine Models of Allergic Asthma
Annette Robichaud*,
Stephanie A. Tuck*,
Stacia Kargman,
John Tam,
Elizabeth Wong,
Mark Abramovitz,
James Mortimer,
Helen E. Burston,
Paul Masson,
Jeremy Hirota,
Deborah Slipetz,
Brian Kennedy,
Gary O'Neill and
Steven Xanthoudakis
Department of Biochemistry & Molecular Biology, and Pharmacology, Merck Frosst Centre for Therapeutic Research, Kirkland, Quebec, Canada
Correspondence and requests for reprints should be addressed to Steven Xanthoudakis, Ph.D., Department of Biochemistry and Molecular Biology, Merck Centre for Therapeutic Research, P.O. Box 1005, Pointe-Claire-Dorval, PQ, H9R 4P8 Canada. E-mail: steven_xanthoudakis{at}merck.com
Overexpression of Gob-5 has previously been linked to goblet cell metaplasia and mucin overproduction in both in vitro and in vivo model systems. In this study, Gob-5 knockout mice were generated and their phenotype was evaluated in two established preclinical models of allergic asthma. We sought to determine whether the Gob-5null animals could produce less mucus in response to allergic challenge, and whether this would have any impact on reducing goblet cell metaplasia and airway inflammation. We found that in the absence of a proinflammatory stimulus we could not detect an overt phenotypic difference between age and sex-matched knockout and wild-type animals. Allergic challenge with ovalbumin or intranasal administration of interleukin-13 produced a robust allergic response that was similar regardless of genotype. In addition, siRNA-mediated knockdown of CLCA-1 in cultured lung epithelial cells failed to reduce mucin expression in vitro. Thus, in contrast to previously published reports, our findings show that Gob-5 expression is not essential for mucin overproduction in vitro or in murine models of allergic asthma. Furthermore, we have also exploited the use of gene expression array analysis to investigate the possibility that a compensatory mechanism, involving other genes, may act to override the requirement for Gob-5mediated mucus overproduction.
This article has been cited by other articles:

|
 |

|
 |
 
M. K. Bothe, J. Braun, L. Mundhenk, and A. D. Gruber
Murine mCLCA6 Is an Integral Apical Membrane Protein of Non-goblet Cell Enterocytes and Co-localizes With the Cystic Fibrosis Transmembrane Conductance Regulator
J. Histochem. Cytochem.,
May 1, 2008;
56(5):
495 - 509.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Wu, J. J. Peluso, J. D. Shanley, L. Puddington, and R. S. Thrall
Murine Cytomegalovirus Influences Foxj1 Expression, Ciliogenesis, and Mucus Plugging in Mice with Allergic Airway Disease
Am. J. Pathol.,
March 1, 2008;
172(3):
714 - 724.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Cheng, Z. Shao, B. Chaudhari, and D. K. Agrawal
Involvement of chloride channels in TGF-beta1-induced apoptosis of human bronchial epithelial cells
Am J Physiol Lung Cell Mol Physiol,
November 1, 2007;
293(5):
L1339 - L1347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Long, J. P. Sypek, R. Askew, S. C. Fish, L. E. Mason, C. M. M. Williams, and S. J. Goldman
Gob-5 Contributes to Goblet Cell Hyperplasia and Modulates Pulmonary Tissue Inflammation
Am. J. Respir. Cell Mol. Biol.,
September 1, 2006;
35(3):
357 - 365.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Holtzman, J. T. Battaile, and A. C. Patel
Immunogenetic Programs for Viral Induction of Mucous Cell Metaplasia
Am. J. Respir. Cell Mol. Biol.,
July 1, 2006;
35(1):
29 - 39.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Erle and G. Zhen
The asthma channel?: stay tuned . . .
Am. J. Respir. Crit. Care Med.,
June 1, 2006;
173(11):
1181 - 1182.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Nakano, H. Inoue, S. Fukuyama, K. Matsumoto, M. Matsumura, M. Tsuda, T. Matsumoto, H. Aizawa, and Y. Nakanishi
Niflumic Acid Suppresses Interleukin-13-induced Asthma Phenotypes
Am. J. Respir. Crit. Care Med.,
June 1, 2006;
173(11):
1216 - 1221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Patel, J. D. Morton, E. Y. Kim, Y. Alevy, S. Swanson, J. Tucker, G. Huang, E. Agapov, T. E. Phillips, M. E. Fuentes, et al.
Genetic segregation of airway disease traits despite redundancy of calcium-activated chloride channel family members
Physiol Genomics,
May 16, 2006;
25(3):
502 - 513.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 American Thoracic Society.
|
|
|